Papers

2

Total Citations

15

H-Index

2

About

Katharina Leucht is a leading urologic surgeon and clinical researcher whose work is reshaping the surgical management of kidney and prostate cancers. Her primary research areas center on robotic-assisted surgery, comparative effectiveness trials, and post-operative complication management in urologic oncology. Dr. Leucht’s most impactful contribution is the OpeRa trial, a landmark prospective, randomized, multicenter study that directly compared robotic-assisted partial nephrectomy (RAPN) to open partial nephrectomy (OPN) for intermediate- and high-complexity kidney tumors. With 12 citations since its 2025 publication, this work provides critical, high-level evidence on whether robotic techniques reduce 30-day complications, addressing a key debate in the field. She has also conducted important retrospective analyses on vesicourethral anastomotic strictures following robotic radical prostatectomy, identifying radiotherapy as a significant risk factor. By generating rigorous data from randomized controlled trials, Dr. Leucht is helping to define best practices and improve outcomes for patients undergoing complex urologic surgeries.

Research Focus

Key Achievements

2
H-Index
2
Papers
15
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Open versus robotic-assisted partial nephrectomy in patients with intermediate/high-complexity kidney tumours: final results of the randomised, controlled, open-label, multicentre trial OpeRa
12 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 20
🏛 Institutions: Jena University Hospital, Comprehensive Cancer Center Mainfranken

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago